Claire Saule

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesions.

Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesions.

Journal: Gynecologic oncology

Published: December 18, 2025

BARD1 and breast cancer genetic predisposition: case-control study and HRD signature analysis.

BARD1 and breast cancer genetic predisposition: case-control study and HRD signature analysis.

Journal: Breast cancer (Tokyo, Japan)

Published: December 05, 2025

Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study).

Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study).

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 22, 2025

Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort study.

Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort study.

Journal: EClinicalMedicine

Published: January 21, 2025

Prophylactic breast surgery in high-risk breast cancer patients

Prophylactic breast surgery in high-risk breast cancer patients

Journal: Bulletin du cancer

Published: December 06, 2024

Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh-frozen breast/ovarian tumor versus blood.

Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh-frozen breast/ovarian tumor versus blood.

Journal: Clinical genetics

Published: January 19, 2023

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 25, 2022

Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer.

Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer.

Journal: ESMO open

Published: September 16, 2021

Prevalent versus incident breast cancers: benefits of clinical and radiological monitoring in women with pathogenic BRCA1/2 variants.

Prevalent versus incident breast cancers: benefits of clinical and radiological monitoring in women with pathogenic BRCA1/2 variants.

Journal: European journal of human genetics : EJHG

Published: August 02, 2021

Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

Journal: American journal of human genetics

Published: June 15, 2021

Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.

Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.

Journal: Cancers

Published: November 02, 2020

Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants.

Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants.

Journal: NPJ breast cancer

Published: September 15, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026